Behind the Study: Anticancer Potential of CLK Kinase Inhibitors 1C8 and GPS167
May 30, 2024
Dr. Benoit Chabot from Université de Sherbrooke discusses a research paper he co-authored that was published by Oncotarget, entitled, “The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167... read more